Filter your results
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt CohortHepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01769633v1
|
|||
Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt CohortHepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01684629v1
|
|||
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)Hepatology, 2017, 66, pp.873A-874A
Journal articles
hal-01769634v1
|